Meng Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Meng Meng has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Rimo Xi
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China
16 shared publications Yongmei Yin
State Key Laboratory of Medicinal Chemical Biology College of Pharmacy and KLMDASR of Tianjin Nankai University Tianjin 300350 China
13 shared publicationsYanqi Qiao
Department of Rehabilitation, Second Hospital of Shandong University, No. 247, Beiyuan Avenue, Jinan 250033, Shandong, China
11 shared publicationsRimo Xi
State Key Laboratory of Medicinal Chemical Biology College of Pharmacy and KLMDASR of Tianjin Nankai University Tianjin P. R. China
10 shared publications- Xiujie Zhao
Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China
9 shared publications - Yongmei Yin
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, Tongyan Road, Haihe Education Park, Tianjin 300350, China
9 shared publications
Latest Publications
- 8 November 2026
- Published by Wiley in Advanced Healthcare Materials
A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy
Pyroptosis, a lytic and inflammatory form of programmed cell death, provides a promising strategy for antitumor immunotherapy. However, controllable modulation of pyroptosis using phototherapeutic agents remains challenging. In this study, we report a two‐stage molecular reprogramming method to rationally design cyanine photosensitizers with tunable pyroptosis‐inducing activity. We first reprogram IR808 into a novel photosensitizer T808, by integrating a tetraphenylethylene unit with IR808, which consequently enhances excited ‐ state features related to intersystem crossing (ISC) and reactive oxygen species (ROS) generation capability, accompanied by inducing pyroptosis under irradiation. In the second process, T808 is conjugated with poly(ethylene glycol) (PEG) chains of varying lengths (M.W. 550, 1000, and 2000 Da) to finely modulate the pyroptotic efficacy. The relationship of PEG chain length with pyroptosis‐inducing activity is in the order of PT550 > T808 > PT1000 >> PT2000. Cellular and in vivo studies show that T808, PT550, and PT1000 treatments suppress tumor growth and induce pyroptosis with occurrence of immunogenic cell death (ICD). Even under a lower intratumoral injection dose (25 µM), T808 and PT550 therapies exhibit remarkable antitumor efficacy with measurable pyroptosis features. This work provides a new insight into reprogramming cyanine photosensitizers into pyroptosis‐active molecules, and proposes possible structural association of PEGylated cyanines with the pyroptosis activity.
- 8 November 2026
- Published by Wiley in Advanced Healthcare Materials
A Two‐Stage Strategy to Reprogram Cyanine Photosensitizers as Controllable‐Pyroptosis Inducers for Anticancer Phototherapy
Pyroptosis, a lytic and inflammatory form of programmed cell death, provides a promising strategy for antitumor immunotherapy. However, controllable modulation of pyroptosis using phototherapeutic agents remains challenging. In this study, we report a two‐stage molecular reprogramming method to rationally design cyanine photosensitizers with tunable pyroptosis‐inducing activity. We first reprogram IR808 into a novel photosensitizer T808, by integrating a tetraphenylethylene unit with IR808, which consequently enhances excited ‐ state features related to intersystem crossing (ISC) and reactive oxygen species (ROS) generation capability, accompanied by inducing pyroptosis under irradiation. In the second process, T808 is conjugated with poly(ethylene glycol) (PEG) chains of varying lengths (M.W. 550, 1000, and 2000 Da) to finely modulate the pyroptotic efficacy. The relationship of PEG chain length with pyroptosis‐inducing activity is in the order of PT550 > T808 > PT1000 >> PT2000. Cellular and in vivo studies show that T808, PT550, and PT1000 treatments suppress tumor growth and induce pyroptosis with occurrence of immunogenic cell death (ICD). Even under a lower intratumoral injection dose (25 µM), T808 and PT550 therapies exhibit remarkable antitumor efficacy with measurable pyroptosis features. This work provides a new insight into reprogramming cyanine photosensitizers into pyroptosis‐active molecules, and proposes possible structural association of PEGylated cyanines with the pyroptosis activity.
- 19 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (34) , 24909-24920
cRGD-Functionalized Calcium Carbonate Nanoprobe for Enhanced NIR-II Fluorescence Imaging and Tumor-Targeted Navigation
Indocyanine green (ICG) holds promise for near-infrared-II (NIR-II) fluorescence imaging but is hindered by poor photostability, rapid clearance, and lack of targeting specificity. To address these challenges, we engineered a tumor-targeted nanoprobe (cRGD@ICN) by encapsulating ICG within a calcium carbonate (CaCO3) core, followed by surface functionalization with phospholipids and cyclic RGD (cRGD) peptides. The CaCO3 encapsulation enhanced ICG photostability and amplified NIR-II emission by 9.21-fold relative to free ICG. Meanwhile, cRGD conjugation enabled active targeting of integrin αvβ3, a receptor overexpressed on diverse tumor types. cRGD@ICN showed receptor-mediated endocytosis with specific uptake in HCT116, 4T1, and U87 cells in vitro, along with selective accumulation in human ex vivo colorectal cancer tissues. In vivo NIR-II fluorescence imaging revealed that cRGD@ICN achieved high-contrast tumor monitoring with a signal-to-background ratio (SBR) of 6.54 at 16 h postinjection in HCT116 tumor-bearing mice─markedly outperforming the nontargeted control. More importantly, it also exhibited remarkable tumor-targeting ability across other tumor models (U87, 4T1). With precise tumor imaging, we performed real-time NIR-II fluorescence-guided resection of colorectal tumors, confirmed by the absence of residual tumor in the surgical cavity by H&E analysis. Moreover, primary biosafety assessments confirmed favorable biocompatibility. This work provides a promising strategy to transform ICG into a high-performance NIR-II fluorescent nanoprobe and offers a potential approach for precision image-guided oncologic surgery.
- 19 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (34) , 24909-24920
cRGD-Functionalized Calcium Carbonate Nanoprobe for Enhanced NIR-II Fluorescence Imaging and Tumor-Targeted Navigation
Indocyanine green (ICG) holds promise for near-infrared-II (NIR-II) fluorescence imaging but is hindered by poor photostability, rapid clearance, and lack of targeting specificity. To address these challenges, we engineered a tumor-targeted nanoprobe (cRGD@ICN) by encapsulating ICG within a calcium carbonate (CaCO3) core, followed by surface functionalization with phospholipids and cyclic RGD (cRGD) peptides. The CaCO3 encapsulation enhanced ICG photostability and amplified NIR-II emission by 9.21-fold relative to free ICG. Meanwhile, cRGD conjugation enabled active targeting of integrin αvβ3, a receptor overexpressed on diverse tumor types. cRGD@ICN showed receptor-mediated endocytosis with specific uptake in HCT116, 4T1, and U87 cells in vitro, along with selective accumulation in human ex vivo colorectal cancer tissues. In vivo NIR-II fluorescence imaging revealed that cRGD@ICN achieved high-contrast tumor monitoring with a signal-to-background ratio (SBR) of 6.54 at 16 h postinjection in HCT116 tumor-bearing mice─markedly outperforming the nontargeted control. More importantly, it also exhibited remarkable tumor-targeting ability across other tumor models (U87, 4T1). With precise tumor imaging, we performed real-time NIR-II fluorescence-guided resection of colorectal tumors, confirmed by the absence of residual tumor in the surgical cavity by H&E analysis. Moreover, primary biosafety assessments confirmed favorable biocompatibility. This work provides a promising strategy to transform ICG into a high-performance NIR-II fluorescent nanoprobe and offers a potential approach for precision image-guided oncologic surgery.
- 3 February 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115512
An adjuvant codelivery nanosystem using Poria cocos polysaccharide for strengthened antitumor immunophototherapy
- 3 February 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115512
An adjuvant codelivery nanosystem using Poria cocos polysaccharide for strengthened antitumor immunophototherapy
- 3 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (45) , 25223-25231
Controllable Self-Assembly of Amphiphilic Heptamethine Cyanines for Turn-On Fluorescence-Guided Tumor Phototherapy
Heptamethine cyanines are attractive NIR fluorophores for image-guided tumor phototherapy. However, most cyanines exhibit unignorably high background fluorescence, which would lead to low-contrast images in the tumor. Inspired by findings that proper modulations of cyanines can self-quench fluorescence in the aggregated state but retrieve fluorescence when they are switched to the monomer, we herein engineer four amphiphilic heptamethine cyanines (IR780-NCn, n = 3/6/12/18) with extended hydrophobic alkyl chains. By studying the optimal properties and morphology of the dyes, we finally optimize IR780-NC12 and IR780-NC18 which can form nonfluorescent nanoaggregates in PBS but disassemble and recover intense NIR emission in hydrophobic media. Upon cellular uptake, the amphiphilic cyanines show fluorescence in membranous organelles such as mitochondria (IR780-NC3 and IR780-NC6) or the cell membrane (IR780-NC12 and IR780-NC18). Also, hydrophobic shielding enhances ROS generation under laser irradiation, as observed in IR780-NC12 and IR780-NC18. In vivo, IR780-NC18 administration (i.v.) exhibits the brightest and most prolonged tumor fluorescence up to 96 h. Guided by the NIR images in the tumor, an efficient PTT/PDT antitumor effect is confirmed for IR780-NC12 and IR780-NC18 phototherapy. We believe that self-assembly tuning design is a simple and powerful strategy to develop fluorescent "turn-on" cyanines as high-contrast NIR theranostic agents to guide tumor phototherapy.
- 3 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (45) , 25223-25231
Controllable Self-Assembly of Amphiphilic Heptamethine Cyanines for Turn-On Fluorescence-Guided Tumor Phototherapy
Heptamethine cyanines are attractive NIR fluorophores for image-guided tumor phototherapy. However, most cyanines exhibit unignorably high background fluorescence, which would lead to low-contrast images in the tumor. Inspired by findings that proper modulations of cyanines can self-quench fluorescence in the aggregated state but retrieve fluorescence when they are switched to the monomer, we herein engineer four amphiphilic heptamethine cyanines (IR780-NCn, n = 3/6/12/18) with extended hydrophobic alkyl chains. By studying the optimal properties and morphology of the dyes, we finally optimize IR780-NC12 and IR780-NC18 which can form nonfluorescent nanoaggregates in PBS but disassemble and recover intense NIR emission in hydrophobic media. Upon cellular uptake, the amphiphilic cyanines show fluorescence in membranous organelles such as mitochondria (IR780-NC3 and IR780-NC6) or the cell membrane (IR780-NC12 and IR780-NC18). Also, hydrophobic shielding enhances ROS generation under laser irradiation, as observed in IR780-NC12 and IR780-NC18. In vivo, IR780-NC18 administration (i.v.) exhibits the brightest and most prolonged tumor fluorescence up to 96 h. Guided by the NIR images in the tumor, an efficient PTT/PDT antitumor effect is confirmed for IR780-NC12 and IR780-NC18 phototherapy. We believe that self-assembly tuning design is a simple and powerful strategy to develop fluorescent "turn-on" cyanines as high-contrast NIR theranostic agents to guide tumor phototherapy.
- 12 August 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 289, 117860
Fabricating streptavidin-embedded metal-organic frameworks for noninvasive gene detection of Helicobacter pylori infection
- 12 August 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 289, 117860
Fabricating streptavidin-embedded metal-organic frameworks for noninvasive gene detection of Helicobacter pylori infection
- 2 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12338-12346
Dual-Modulation Design to Develop ER-Targeting NIR Pyroptosis Inducers with Type I PDT Efficacy and Amplified Antitumor Immunity
Recently, immunogenic cell death (ICD) activated by phototherapy has attracted increasing attention in anticancer immunotherapy. Pyroptosis, a lysogenic and inflammatory form of cell death distinct from apoptosis, is considered to enhance the ICD process in tumor cells. Endoplasmic reticulum (ER)-targeted pyroptosis induced by phototherapy is reported to promote the release of inflammatory cytokines and DAMPs and amplify ICD response as a result. However, specific and stable tracking of the ER is more difficult than that of other organelles. In this work, we introduce a dual-modulation strategy to regulate the effect of ER-targeting unit p-toluenesulfonamide and twisting conjugation motif on the modification of heptamethine cyanine. A dimer dye (T780T-ER) with twisting structure and four p-toluenesulfonamide molecules is ultimately optimized, which can specifically target ER with good stability and efficient Type I PDT capability. Under PDT/PTT stimulation, T780T-ER activates sufficient pyroptosis and causes the release of inflammatory cytokines and DAMPs. In vivo, promoted ICD response and strengthened antitumor immunity are confirmed against the growth of primary and distant tumors. Summarily, this study highlights the importance of a multiple-modulation strategy in developing ER-targeted photosensitizers and proposes a Type I PDT molecule (T780T-ER) as an ER stress-dependent pyroptosis inducer to enhance antitumor immunotherapy.
- 2 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12338-12346
Dual-Modulation Design to Develop ER-Targeting NIR Pyroptosis Inducers with Type I PDT Efficacy and Amplified Antitumor Immunity
Recently, immunogenic cell death (ICD) activated by phototherapy has attracted increasing attention in anticancer immunotherapy. Pyroptosis, a lysogenic and inflammatory form of cell death distinct from apoptosis, is considered to enhance the ICD process in tumor cells. Endoplasmic reticulum (ER)-targeted pyroptosis induced by phototherapy is reported to promote the release of inflammatory cytokines and DAMPs and amplify ICD response as a result. However, specific and stable tracking of the ER is more difficult than that of other organelles. In this work, we introduce a dual-modulation strategy to regulate the effect of ER-targeting unit p-toluenesulfonamide and twisting conjugation motif on the modification of heptamethine cyanine. A dimer dye (T780T-ER) with twisting structure and four p-toluenesulfonamide molecules is ultimately optimized, which can specifically target ER with good stability and efficient Type I PDT capability. Under PDT/PTT stimulation, T780T-ER activates sufficient pyroptosis and causes the release of inflammatory cytokines and DAMPs. In vivo, promoted ICD response and strengthened antitumor immunity are confirmed against the growth of primary and distant tumors. Summarily, this study highlights the importance of a multiple-modulation strategy in developing ER-targeted photosensitizers and proposes a Type I PDT molecule (T780T-ER) as an ER stress-dependent pyroptosis inducer to enhance antitumor immunotherapy.
- 28 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (14) , 17891-17903
Template-Free Self-Assembly of Hollow Microtubular Covalent Organic Frameworks for Oral Delivery of Insulin
Covalent organic frameworks (COFs) have demonstrated versatile application potential since their discovery. Although the structure of COFs is orderly arranged, the synthesis of controllable macrostructures still faces challenges. Herein, we report, to our knowledge, the first template-free self-assembled COF-18 Å hollow microtubule (MT-COF-18 Å) structure and its use for insulin delivery that exhibits high loading capacity, gastroresistance, and glucose-responsive properties. The hollow MT-COF-18 Å was achieved by a template-free method benefiting from the mixed solvents of mesitylene and dioxane. The formation mechanism and morphology changes with insulin loading and release were observed. In Caco-2 cells, the transferrin-coated system demonstrated enhanced insulin cellular uptake and transcellular transport, which indicated great potential for oral applications. Additionally, the composites presented sustained glycemic control and effective insulin blood concentrations without noticeable toxicity in diabetic rats. This work shows that hollow microtubular COFs hold great promise in loading and delivery of biomolecules.
- 28 March 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (14) , 17891-17903
Template-Free Self-Assembly of Hollow Microtubular Covalent Organic Frameworks for Oral Delivery of Insulin
Covalent organic frameworks (COFs) have demonstrated versatile application potential since their discovery. Although the structure of COFs is orderly arranged, the synthesis of controllable macrostructures still faces challenges. Herein, we report, to our knowledge, the first template-free self-assembled COF-18 Å hollow microtubule (MT-COF-18 Å) structure and its use for insulin delivery that exhibits high loading capacity, gastroresistance, and glucose-responsive properties. The hollow MT-COF-18 Å was achieved by a template-free method benefiting from the mixed solvents of mesitylene and dioxane. The formation mechanism and morphology changes with insulin loading and release were observed. In Caco-2 cells, the transferrin-coated system demonstrated enhanced insulin cellular uptake and transcellular transport, which indicated great potential for oral applications. Additionally, the composites presented sustained glycemic control and effective insulin blood concentrations without noticeable toxicity in diabetic rats. This work shows that hollow microtubular COFs hold great promise in loading and delivery of biomolecules.
- 27 February 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (10) , 12310-12320
Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability
Pyroptosis has been reported to improve the antitumor effect by evoking a more intense immune response and a therapeutic effect. For phototherapy, several photosensitizers have been found to initiate pyroptosis. However, the effect of pyroptosis associated with apoptosis in enhancing the antitumor therapy needs sufficient characterization, especially under long-term treatment. As a NIR photosensitizer, heptamethine cyanines have been discovered for anticancer phototherapy for deep tissue penetration and inherent tumor-targeted capability. However, they are not quite stable for long-term performance. To investigate the effect of pyroptosis along with apoptosis on the anticancer immune responses and phototherapy, here, we chemically modulate the cyanine IR780 to regulate hydrophobicity, stability, and intracellular targeting. Two photosensitizers, T780T-TPP and T780T-TPP-C12, were finally optimized and showed excellent photostability with high photothermal conversion efficiency. Although the cellular uptake of the two molecules was both mediated by OATP transporters, T780T-TPP induced tumor cell death via pyroptosis and apoptosis and accumulated in tumor accumulation, while T780T-TPP-C12 was prone to accumulate in the liver. Ultimately, via one injection-multiple irradiation treatment protocol, T780T-TPP displayed a significant antitumor effect, even against the growth of large tumors (200 mm3).
- 27 February 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (10) , 12310-12320
Synergetic Pyroptosis with Apoptosis Improving Phototherapy of Mitochondria-Targeted Cyanines with Superior Photostability
Pyroptosis has been reported to improve the antitumor effect by evoking a more intense immune response and a therapeutic effect. For phototherapy, several photosensitizers have been found to initiate pyroptosis. However, the effect of pyroptosis associated with apoptosis in enhancing the antitumor therapy needs sufficient characterization, especially under long-term treatment. As a NIR photosensitizer, heptamethine cyanines have been discovered for anticancer phototherapy for deep tissue penetration and inherent tumor-targeted capability. However, they are not quite stable for long-term performance. To investigate the effect of pyroptosis along with apoptosis on the anticancer immune responses and phototherapy, here, we chemically modulate the cyanine IR780 to regulate hydrophobicity, stability, and intracellular targeting. Two photosensitizers, T780T-TPP and T780T-TPP-C12, were finally optimized and showed excellent photostability with high photothermal conversion efficiency. Although the cellular uptake of the two molecules was both mediated by OATP transporters, T780T-TPP induced tumor cell death via pyroptosis and apoptosis and accumulated in tumor accumulation, while T780T-TPP-C12 was prone to accumulate in the liver. Ultimately, via one injection-multiple irradiation treatment protocol, T780T-TPP displayed a significant antitumor effect, even against the growth of large tumors (200 mm3).
Mucus‐Penetrating Nanoassembly as Potential Oral Phototherapeutic Formulation against Multi‐Drug Resistant Helicobacter pylori Infection
Helicobacter pylori (H. pylori) infection presents increasing challenges to antibiotic therapies in limited penetration through gastric mucus, multi‐drug resistance (MDR), biofilm formation, and intestinal microflora dysbiosis. To address these problems, herein, a mucus‐penetrating phototherapeutic nanomedicine (RLs@T780TG) against MDR H. pylori infection is engineered. The RLs@T780TG is assembled with a near‐infrared photosensitizer T780T‐Gu and an anionic component rhamnolipids (RLs) for deep mucus penetration and light‐induced anti‐H. pylori performances. With optimized suitable size, hydrophilicity and weak negative surface, the RLs@T780TG can effectively penetrate through the gastric mucus layer and target the inflammatory site. Subsequently, under irradiation, the structure of RLs@T780TG is disrupted and facilitates the T780T‐Gu releasing to target the H. pylori surface and ablate multi‐drug resistant (MDR) H. pylori. In vivo, RLs@T780TG phototherapy exhibits impressive eradication against H. pylori. The gastric lesions are significantly alleviated and intestinal bacteria balance is less affected than antibiotic treatment. Summarily, this work provides a potential nanomedicine design to facilitate in vivo phototherapy in treatment of H. pylori infection.
Mucus‐Penetrating Nanoassembly as Potential Oral Phototherapeutic Formulation against Multi‐Drug Resistant Helicobacter pylori Infection
Helicobacter pylori (H. pylori) infection presents increasing challenges to antibiotic therapies in limited penetration through gastric mucus, multi‐drug resistance (MDR), biofilm formation, and intestinal microflora dysbiosis. To address these problems, herein, a mucus‐penetrating phototherapeutic nanomedicine (RLs@T780TG) against MDR H. pylori infection is engineered. The RLs@T780TG is assembled with a near‐infrared photosensitizer T780T‐Gu and an anionic component rhamnolipids (RLs) for deep mucus penetration and light‐induced anti‐H. pylori performances. With optimized suitable size, hydrophilicity and weak negative surface, the RLs@T780TG can effectively penetrate through the gastric mucus layer and target the inflammatory site. Subsequently, under irradiation, the structure of RLs@T780TG is disrupted and facilitates the T780T‐Gu releasing to target the H. pylori surface and ablate multi‐drug resistant (MDR) H. pylori. In vivo, RLs@T780TG phototherapy exhibits impressive eradication against H. pylori. The gastric lesions are significantly alleviated and intestinal bacteria balance is less affected than antibiotic treatment. Summarily, this work provides a potential nanomedicine design to facilitate in vivo phototherapy in treatment of H. pylori infection.
- Open Access
- 6 April 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (15) , 8408-8416
Reversible Recognition-Based Boronic Acid Probes for Glucose Detection in Live Cells and Zebrafish
- 6 April 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (15) , 8408-8416
Open AccessReversible Recognition-Based Boronic Acid Probes for Glucose Detection in Live Cells and Zebrafish